The item has been added to your shopping cart.
Home » DYAX AND TRUBION COLLABORATE ON THERAPEUTICS AND DIAGNOSTICS DISCOVERY
DYAX AND TRUBION COLLABORATE ON THERAPEUTICS AND DIAGNOSTICS DISCOVERY
October 10, 2006
Dyax entered into a nonexclusive agreement with Trubion Pharmaceuticals in the fields of protein therapeutics and diagnostics discovery. Under the agreement, Dyax will utilize its phage display libraries for the discovery of compounds that bind with high affinity and specificity to Trubion's targets in the oncology and inflammation area.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=6550740)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct